Aurealis Therapeutics Proudly Sponsors EWMA Diabetic Foot Committee
Aurealis Therapeutics is pleased to announce our sponsorship of the newly established EWMA Diabetic Foot Committee, an initiative launched by the European Wound Management Association (EWMA) in 2023. This committee is dedicated to improving the management and care of diabetic foot ulcers (DFUs) across Europe by implementing an International Working Group on the Diabetic Foot […]
